MoneyWorks4Me

Ajanta Pharma - Quaterly Results

30 Jan 2025 Evaluate
The company's total revenue for the quarter ended December 2024 saw a slight change in the total revenue, having registered a total revenue of Rs. 11019.20 millions.Profit saw a slight increase of 14.67%to Rs. 2524.50  millions from Rs. 2201.50 millions.Operating profit for the quarter ended December 2024 rose to 3695.60 millions as compared to 3409.10 millions of corresponding quarter ended December 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 11019.20 10852.90 1.53 33081.00 30450.50 8.64 39711.20 34112.70 16.41
Other Income 332.30 137.30 142.02 1019.40 973.50 4.71 1164.80 1327.50 -12.26
PBIDT 3695.60 3409.10 8.40 10570.10 9750.80 8.40 12359.10 8320.30 48.54
Interest 24.80 23.60 5.08 39.30 53.80 -26.95 68.00 52.30 30.02
PBDT 3670.80 3385.50 8.43 10530.80 9697.00 8.60 12291.10 8268.00 48.66
Depreciation 349.30 334.10 4.55 1011.70 986.90 2.51 1321.60 1269.50 4.10
PBT 3321.50 3051.40 8.85 9519.10 8710.10 9.29 10969.50 6998.50 56.74
TAX 797.00 849.90 -6.22 2284.50 2264.60 0.88 2897.10 1411.30 105.28
Deferred Tax 33.20 30.50 8.85 95.20 87.10 9.30 121.30 -29.30 -513.99
PAT 2524.50 2201.50 14.67 7234.60 6445.50 12.24 8072.40 5587.20 44.48
Equity 250.70 252.70 -0.79 250.70 252.70 -0.79 252.70 252.70 0.00
PBIDTM(%) 33.54 31.41 6.77 31.95 32.02 -0.22 31.12 24.39 27.60
Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.00
View more..